2025. Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s717. DOI:https://doi.org/10.25251/kvstvq23.